790 related articles for article (PubMed ID: 28728898)
21. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin.
Gardiner DL; Trenholme KR; Skinner-Adams TS; Stack CM; Dalton JP
J Biol Chem; 2006 Jan; 281(3):1741-5. PubMed ID: 16286469
[TBL] [Abstract][Full Text] [Related]
22. X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17.
Drinkwater N; Bamert RS; Sivaraman KK; Paiardini A; McGowan S
Proteins; 2015 Apr; 83(4):789-95. PubMed ID: 25645579
[TBL] [Abstract][Full Text] [Related]
23. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors.
Sahi S; Raj U; Chaudhary M; Nain V
Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653
[TBL] [Abstract][Full Text] [Related]
24. Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.
Gupta D; Yedidi RS; Varghese S; Kovari LC; Woster PM
J Med Chem; 2010 May; 53(10):4234-47. PubMed ID: 20438064
[TBL] [Abstract][Full Text] [Related]
25. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
[TBL] [Abstract][Full Text] [Related]
26. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
[TBL] [Abstract][Full Text] [Related]
27. Plasmodium falciparum M1-aminopeptidase: a promising target for the development of antimalarials.
González-Bacerio J; Fando R; del Monte-Martínez A; Charli JL; Chávez Mde L
Curr Drug Targets; 2014; 15(12):1144-65. PubMed ID: 25341419
[TBL] [Abstract][Full Text] [Related]
28. On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
Edgar RCS; Malcolm TR; Siddiqui G; Giannangelo C; Counihan NA; Challis M; Duffy S; Chowdhury M; Marfurt J; Dans M; Wirjanata G; Noviyanti R; Daware K; Suraweera CD; Price RN; Wittlin S; Avery VM; Drinkwater N; Charman SA; Creek DJ; de Koning-Ward TF; Scammells PJ; McGowan S
mBio; 2024 Jun; 15(6):e0096624. PubMed ID: 38717141
[TBL] [Abstract][Full Text] [Related]
29. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
[TBL] [Abstract][Full Text] [Related]
30. The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum.
Teuscher F; Lowther J; Skinner-Adams TS; Spielmann T; Dixon MW; Stack CM; Donnelly S; Mucha A; Kafarski P; Vassiliou S; Gardiner DL; Dalton JP; Trenholme KR
J Biol Chem; 2007 Oct; 282(42):30817-26. PubMed ID: 17720817
[TBL] [Abstract][Full Text] [Related]
31. Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.
Harbut MB; Velmourougane G; Dalal S; Reiss G; Whisstock JC; Onder O; Brisson D; McGowan S; Klemba M; Greenbaum DC
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E526-34. PubMed ID: 21844374
[TBL] [Abstract][Full Text] [Related]
32. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.
Maric S; Donnelly SM; Robinson MW; Skinner-Adams T; Trenholme KR; Gardiner DL; Dalton JP; Stack CM; Lowther J
Biochemistry; 2009 Jun; 48(23):5435-9. PubMed ID: 19408962
[TBL] [Abstract][Full Text] [Related]
33. Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death.
Serrán-Aguilera L; Denton H; Rubio-Ruiz B; López-Gutiérrez B; Entrena A; Izquierdo L; Smith TK; Conejo-García A; Hurtado-Guerrero R
Sci Rep; 2016 Sep; 6():33189. PubMed ID: 27616047
[TBL] [Abstract][Full Text] [Related]
34. KBE009: A Bestatin-Like Inhibitor of the
González-Bacerio J; Arocha I; Aguado ME; Méndez Y; Marsiccobetre S; Izquierdo M; Rivera DG; Figarella K; Uzcátegui NL
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685408
[TBL] [Abstract][Full Text] [Related]
35. Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
Vinh NB; Drinkwater N; Malcolm TR; Kassiou M; Lucantoni L; Grin PM; Butler GS; Duffy S; Overall CM; Avery VM; Scammells PJ; McGowan S
J Med Chem; 2019 Jan; 62(2):622-640. PubMed ID: 30537832
[TBL] [Abstract][Full Text] [Related]
36. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of malaria parasite growth by quinomycin A and its derivatives through DNA-intercalating activity.
Hayase H; Watanabe N; Lim CL; Nogawa T; Komatsuya K; Kita K; Osada H
Biosci Biotechnol Biochem; 2015; 79(4):633-5. PubMed ID: 25471083
[TBL] [Abstract][Full Text] [Related]
38. Aminobenzosuberone derivatives as PfA-M1 inhibitors: Molecular recognition and antiplasmodial evaluation.
Salomon E; Schmitt M; Mouray E; McEwen AG; Bounaadja L; Torchy M; Poussin-Courmontagne P; Alavi S; Tarnus C; Cavarelli J; Florent I; Albrecht S
Bioorg Chem; 2020 May; 98():103750. PubMed ID: 32182520
[TBL] [Abstract][Full Text] [Related]
39. Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity.
Siyah P; Akgol S; Durdagi S; Kocabas F
Biochem J; 2021 Sep; 478(18):3445-3466. PubMed ID: 34486667
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors.
Flipo M; Florent I; Grellier P; Sergheraert C; Deprez-Poulain R
Bioorg Med Chem Lett; 2003 Aug; 13(16):2659-62. PubMed ID: 12873488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
